Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus

By sjmartinez • January 27, 2025

Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Böhmig GA, Boletis J, Briggs D, Claas FHJ, Couzi L, Cozzi E, Crespo M, De Vries APJ, Diekmann F, Durlik M, Glotz D, Helantera I, Jackson A, Jordan SC, Kuypers D, Lefaucheur C, Legendre C, Lorant T, Maggiore U, Mamode N, Marinaki S, Massart A, Müller T, Oberbauer R, Renders L, Roelen D, Taupin JL, Viklický O, Vittoraki A, de Weerd AE, Naesens M. Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus. Transpl Int. 2025 Jan 6;37:13886. doi: 10.3389/ti.2024.13886. PMID: 39867871; PMCID: PMC11758882.

Tags: desensitization, HLA incompatible, HLAi, imlifidase, kidney transplantation, Nephrology, Publications

Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”

Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int[...]

Hyponatremia treatment guidelines: a necessary course correction

Moritz ML, Ciapponi A, Hsu CY, Nigwekar SU, Singhal AB, Rhee CM, Kalantar-Zadeh K, Waikar S, Kovesdy CP, Ayus JC. Hyponatremia treatment guidelines: a necessary[...]

The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers

Rastogi A, Magay Y, Kady Y. The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers. Adv Ther. 2026 Jul 30. doi:[...]